Total current assets Total assets Related and Nonrelated Parties [Axis] Total current liabilities Total liabilities Total Quest Patent Research Corporation stockholders’ deficit Total stockholders’ deficit Balance Balance Total liabilities and stockholders’ deficit Gross (loss) margin Total operating expenses Loss from operations Total other income (expense) Loss before income tax Net loss Net loss Loss amount Balance (in Shares) Balance (in Shares) Equity Components [Axis] Net cash used in operating activities Net cash used in investing activities Net cash provided by financing activities Net decrease in cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Description of Business [Abstract] Summary of Significant Accounting Policies [Abstract] Intangible Assets [Abstract] Finite-Lived Intangible Assets by Major Class [Axis] Net value of intangible assets Patents, net of accumulated amortization of $4,856,737 and $3,048,750, respectively Schedule of Future Amortization of Intangible Assets [Abstract] Short-Term Debt and Long-Term Liabilities [Abstract] Related Party Transaction [Axis] Warrant Liability [Abstract] Measurement Input Type [Axis] Class of Warrant or Right [Axis] Fair Value Hierarchy and NAV [Axis] Beginning balance Ending Balance Warrant liability Total liabilities Outstanding warrants Stockholders’ Equity [Abstract] Schedule of Stock Options [Abstract] Number of Options, Ending Balance (in Shares) Weighted Average Exercise Price, Ending Balance Weighted Average Grant Date Fair Value, Ending Balance Number of Warrants, Ending Balance Weighted Average Exercise Price, Ending Balance Non-Controlling Interest [Abstract] Balance, beginning of year Balance, end of year Non-controlling interest in subsidiary Income Taxes [Abstract] Schedule of Deferred Tax Assets and Liabilities [Abstract] Balance, end of year Schedule of Tax Expense {Abstract] Total Income tax expense Total, Amount (in Dollars) Related Party Transactions [Abstract] Segment Information [Abstract] Commitments and Contingencies [Abstract] ASSETS Current assets Cash and cash equivalents Accounts receivable, net of allowance for credit losses of $0 and $0, respectively Accounts receivable, net of allowance for credit losses Other current assets Patents, net of accumulated amortization Less: accumulated amortization LIABILITIES AND STOCKHOLDERS’ DEFICIT Current liabilities Accounts payable and accrued liabilities ($10,000 and $11,041 due to related parties, respectively) Accounts payable and accrued liabilities, due to related parties Loans payable Funding liability Funding liabilities Loan payable - related party Accrued interest Non-current liabilities Loan payable – SBA Purchase price of patents Commitments and contingencies (Note 11) Stockholders’ deficit: Preferred stock, par value $0.00003 per share - authorized 10,000,000 shares - no shares issued and outstanding Preferred stock, par value (in Dollars per share) Preferred stock, shares authorized (in Shares) Preferred stock, shares issued (in Shares) Preferred stock, shares outstanding (in Shares) Common stock, par value $0.00003 per share; authorized 30,000,000 at December 31, 2025 and 2024; 5,331,973 shares issued and outstanding at December 31, 2025 and 2024 Common stock, par value (in Dollars per share) Common stock, shares authorized (in Shares) Common stock, shares issued (in Shares) Common stock, shares outstanding (in Shares) Additional paid-in capital Accumulated deficit Revenues Patent licensing fees Cost of revenue Litigation and licensing expenses Operating expenses Selling, general and administrative expenses Other income (expense) Loss per share - basic (in Dollars per share) Loss per share - diluted (in Dollars per share) Weighted average shares outstanding - basic (in Shares) Weighted average shares outstanding - diluted (in Shares) Stock-based compensation Cash flows from operating activities: Adjustments to reconcile net loss to cash used in operating activities: Change in fair market value of warrant liability Change in fair market value of warrant liability Gain (loss) on subsequent measurement Stock-based compensation Amortization of intangible assets Amortization expense for patents (in Dollars) Change in operating assets and liabilities: Accrued interest Accounts payable and accrued liabilities Cash flows from investing activities: Cash flows from financing activities: Proceeds from funding liability Non-cash investing and financing activities: Interest added to principal Supplemental disclosure of cash flow information: Cash paid during the period for: Income taxes Interest Interest expense Accounts receivable Other current assets Purchase of intangible assets Payment of funding liability Related Party Common Stock Common Stock [Member] Additional Paid-In Capital Accumulated Deficit Non-controlling Interest in Subsidiaries DESCRIPTION OF BUSINESS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES INTANGIBLE ASSETS Schedule of Intangible Assets Intangible assets, gross Weighted Average Amortization Period (Years) Schedule of Future Amortization of Intangible Assets 2026 2027 2028 2029 Thereafter SHORT-TERM DEBT AND LONG-TERM LIABILITIES Schedule of Company’s Funding Liabilities WARRANT LIABILITY Schedule of Estimated Fair Value of Warrant Liability Warrant liability Schedule of Financial Instruments Liabilities Schedule of Fair Value of Warrant Liabilities STOCKHOLDERS’ EQUITY Schedule of Stock Options Weighted Average Remaining Contractual Life (Years), Ending Balance Number of Options, Granted (in Shares) Granted option Weighted Average Exercise Price, Granted Weighted Average Grant Date Fair Value, Granted Number of Options, Exercised (in Shares) Weighted Average Exercise Price, Exercised Weighted Average Grant Date Fair Value, Exercised Weighted Average Exercise Price, Expired Weighted Average Grant Date Fair Value, Expired Number of Options, Cancelled (in Shares) Weighted Average Exercise Price, Cancelled Weighted Average Grant Date Fair Value, Cancelled Number of Options, Options exercisable at end of period (in Shares) Share purchase Weighted Average Exercise Price, Options exercisable at end of period Price per share (in Dollars per share) Weighted Average Grant Date Fair Value, Options exercisable at end of period Weighted Average Remaining Contractual Life (Years), Options exercisable at end of period Schedule of Warrants Weighted Average Remaining Contractual Life (Years), Ending Balance Number of Warrants, Granted Weighted Average Exercise Price, Granted Number of Warrants, Exercised Weighted Average Exercise Price, Exercised Number of Warrants, Expired Weighted Average Exercise Price, Expired Number of Warrants, Cancelled Weighted Average Exercise Price, cancelled NON-CONTROLLING INTEREST Schedule of Equity Attributable to the Non-Controlling Interest Net loss attributable to non-controlling interest INCOME TAXES Schedule of Deferred Tax Assets and Liabilities Net operating loss carry forward Intangible assets Stock-Based Compensation Foreign Tax Credit Schedule of Tax Expense Federal State Foreign Deferred Schedule of Effective Tax Rate U.S. federal statutory rate, Amount (in Dollars)